Best Peptides for Anti-Aging & Longevity
Russian bioregulators, senolytics, mitochondrial peptides, and the copper tripeptide. Decades of Khavinson research plus the new wave of senescent-cell clearance. Full longevity toolkit.
What's Actually Working
Compounds with the strongest trial data. Each card links to the full research deep-dive.
Epitalon (AEDG)
4-amino-acid tetrapeptide. Re-activates telomerase in somatic cells. Modulates pineal gland function and melatonin rhythms. Khavinson's flagship longevity bioregulator.
GHK-Cu
Copper-binding tripeptide with wide gene-expression effects. Skin, hair, wound healing, and longevity-gene signaling. Best-studied natural longevity compound.
Pinealon + Epitalon
The canonical Russian longevity duo. Epitalon handles telomerase + pineal axis; Pinealon (3-aa tripeptide) handles neuronal protein synthesis. Complementary mechanisms.
Fisetin
Strawberry-derived flavonoid. Most potent natural senolytic identified. Clears senescent cells, modulates SIRT1, elevates BDNF. OTC alternative to D+Q.
Senolytics (D+Q)
Dasatinib + Quercetin combo. Selectively clears senescent cells via BCL-2 pathway disruption. Mayo Clinic Phase 2 data. Prescription required for dasatinib.
MOTS-c
Mitochondrial-derived peptide. Regulates metabolic homeostasis and exercise-induced benefits. Emerging mitohormesis research.
Common Combinations
Russian Longevity Stack
Extended bioregulator combinations: Epitalon + Pinealon + Thymalin + Cartalax. The full Khavinson protocol.
Read more →Bioregulators Guide
The full Khavinson peptide family — organ-specific bioregulators for every tissue type. Practical protocols.
Read more →Senolytic Protocols
D+Q vs Fisetin. Cycling frequency, combining with nutrition, and what the Mayo Phase 2 data actually shows.
Read more →At a Glance
Frequently Asked Questions
Where should I start with longevity peptides?
Start with GHK-Cu (widest evidence, topical or SC), add Epitalon for the telomerase/pineal axis, and consider adding fisetin as your senolytic. That three-compound foundation covers the main longevity mechanisms.
Is telomerase activation dangerous?
Theoretically yes — telomerase is upregulated in ~85% of cancers. Practically: Khavinson's clinical data spans 25+ years without excess cancer signal. Most protocols cycle (10-20 days on, 10-20 days off) rather than continuous dosing.
Fisetin or D+Q for senolytics?
Fisetin alone is the OTC option — simpler, safer, weaker. D+Q requires a prescription for dasatinib but has the strongest human data (Mayo Phase 2). Most users start with fisetin.
How often should I cycle?
Khavinson's original protocols use 10-20 day cycles with similar off-time, 2-3 cycles per year. Senolytics are monthly hit-and-run. GHK-Cu can be daily (especially topical). Mitochondrial peptides weekly.
🔬 Research-Grade Source
Swiss Chems stocks third-party HPLC-tested peptides with published COAs per batch. HighPeptides' primary vendor reference.
Browse Swiss Chems →Affiliate link — supports HighPeptides at no extra cost
Key Takeaways
- Epitalon re-activates telomerase in vitro — core longevity mechanism
- GHK-Cu modulates ~4000 genes and has the widest evidence base
- Senolytic intermittent dosing extends healthspan in mouse studies (D+Q)
- Russian bioregulator clinical record spans 25+ years without major safety signal
- Fisetin provides OTC senolytic access with real (though weaker) evidence
- Mitochondrial peptides (MOTS-c, SS-31) represent emerging anti-aging frontier
- No large human RCT with mortality endpoints for any peptide in this category
- Telomerase activation has theoretical cancer concern
- Russian clinical data has limited Western replication
- Long-term (decade+) human safety of repeated cycles is not rigorously characterized
- Quality variance across vendors is high — third-party COAs are mandatory
Supporting Pages
15 related research pages covering specific questions, compounds, and edge cases.
Bioregulators and longevity peptides are research-use only. No compound on this page is FDA-approved as a longevity or anti-aging therapy.
Not medical advice. Always consult a qualified healthcare provider. Research use only.